Role of COX-2 inhibitors in cancer therapy

被引：30

作者：

Blanke, C ^{[1
]}

机构：

[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

来源：

CANCER INVESTIGATION | 2004年 / 22卷 / 02期

关键词：

COX-2; inhibitor; human malignancy;

D O I：

10.1081/CNV-120030216

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：271 / 282

页数：12

共 109 条

[61] Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse [J].

Milas, L .

SEMINARS IN RADIATION ONCOLOGY, 2001, 11 (04) :290-299

[62] A PROTECTIVE EFFECT OF SULINDAC AGAINST CHEMICALLY-INDUCED PRIMARY COLONIC TUMORS IN MICE [J].

MOORGHEN, M ;

INCE, P ;

FINNEY, KJ ;

SUNTER, JP ;

APPLETON, DR ;

WATSON, AJ .

JOURNAL OF PATHOLOGY, 1988, 156 (04) :341-347

[63]

Morris CD, 2001, AM J GASTROENTEROL, V96, P990

[64] Risk of cardiovascular events associated with selective COX-2 inhibitors [J].

Mukherjee, D ;

Nissen, SE ;

Topol, EJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (08) :954-959

[65] INHIBITION OF ASPIRIN OF N-[4-(5-NITRO-2-FURYL)-2-THIAZOLYL]FORMAMIDE-INDUCED BLADDER CARCINOGENESIS AND ENHANCEMENT OF FORESTOMACH CARCINOGENESIS [J].

MURASAKI, G ;

ZENSER, TV ;

DAVIS, BB ;

COHEN, SM .

CARCINOGENESIS, 1984, 5 (01) :53-55

[66] ARACHIDONIC-ACID METABOLISM [J].

NEEDLEMAN, P ;

TURK, J ;

JAKSCHIK, BA ;

MORRISON, AR ;

LEFKOWITH, JB .

ANNUAL REVIEW OF BIOCHEMISTRY, 1986, 55 :69-102

[67] RANDOMIZED CONTROLLED TRIAL OF THE EFFECT OF SULINDAC ON DUODENAL AND RECTAL POLYPOSIS AND CELL-PROLIFERATION IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS [J].

NUGENT, KP ;

FARMER, KCR ;

SPIGELMAN, AD ;

WILLIAMS, CB ;

PHILLIPS, RKS .

BRITISH JOURNAL OF SURGERY, 1993, 80 (12) :1618-1619

[68]

Ohno R, 2001, CANCER, V91, P1876, DOI 10.1002/1097-0142(20010515)91:10<1876::AID-CNCR1209>3.3.CO

[69]

2-8

[70]

Oshima M, 2001, CANCER RES, V61, P1733

← 2 3 4 5 6 7 8 9 10 11 →